Yuanyuan Kong

26PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMedical biochemistry - lipidsPacific Peoples diet and nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 03, 2026
Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy.

|Mar 14, 2026
Clinical Trials for Curing Chronic Hepatitis B: A Comprehensive Analysis of Trial Design Considerations and Their Association With Trial Performance.

Lichen Shi, Hao Wang, Cheng Huang

|Nov 27, 2025
Impact of Alanine Transaminase Thresholds on Treatment Eligibility of Patients with Chronic Hepatitis B: A Cross-sectional Study of the China Registry of Hepatitis B.

Hao Wang, Xiaoqian Xu, Shan Shan

|Nov 14, 2025
Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies.

Jiayi Zhang, Shuyan Chen, Jialing Zhou

|Sep 23, 2025
Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights From Super and Poor Survivors With Prognostic Signature Identification.

Xiao Qian Xu, Hao Wang, Li Chen Shi

|Sep 02, 2025
Impact of temporary atezolizumab and bevacizumab interruption on survival in advanced HCC: an IMbrave150 analysis.

Xiao-Qian Xu, Wei-Ming Li, Li-Chen Shi

Pageof 5

Frequent Collaborators

13 joint publications

Jidong Jia

8 joint publications

Hong You

4 joint publications

Min Li

3 joint publications

Zhongtao Zhang